Correlation Between Sarofim Equity and Ultra-short Term

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sarofim Equity and Ultra-short Term at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sarofim Equity and Ultra-short Term into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sarofim Equity and Ultra Short Term Fixed, you can compare the effects of market volatilities on Sarofim Equity and Ultra-short Term and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sarofim Equity with a short position of Ultra-short Term. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sarofim Equity and Ultra-short Term.

Diversification Opportunities for Sarofim Equity and Ultra-short Term

-0.14
  Correlation Coefficient

Good diversification

The 3 months correlation between Sarofim and Ultra-short is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Sarofim Equity and Ultra Short Term Fixed in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ultra Short Term and Sarofim Equity is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sarofim Equity are associated (or correlated) with Ultra-short Term. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ultra Short Term has no effect on the direction of Sarofim Equity i.e., Sarofim Equity and Ultra-short Term go up and down completely randomly.

Pair Corralation between Sarofim Equity and Ultra-short Term

Assuming the 90 days horizon Sarofim Equity is expected to under-perform the Ultra-short Term. In addition to that, Sarofim Equity is 25.99 times more volatile than Ultra Short Term Fixed. It trades about -0.29 of its total potential returns per unit of risk. Ultra Short Term Fixed is currently generating about -0.04 per unit of volatility. If you would invest  976.00  in Ultra Short Term Fixed on October 8, 2024 and sell it today you would lose (1.00) from holding Ultra Short Term Fixed or give up 0.1% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Sarofim Equity  vs.  Ultra Short Term Fixed

 Performance 
       Timeline  
Sarofim Equity 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sarofim Equity has generated negative risk-adjusted returns adding no value to fund investors. In spite of weak performance in the last few months, the Fund's primary indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the fund investors.
Ultra Short Term 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Ultra Short Term Fixed are ranked lower than 5 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong basic indicators, Ultra-short Term is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Sarofim Equity and Ultra-short Term Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sarofim Equity and Ultra-short Term

The main advantage of trading using opposite Sarofim Equity and Ultra-short Term positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sarofim Equity position performs unexpectedly, Ultra-short Term can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ultra-short Term will offset losses from the drop in Ultra-short Term's long position.
The idea behind Sarofim Equity and Ultra Short Term Fixed pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities